KILL Agilent xCELLigence RTCA Instrumentation Applied in Recent FDA Approval

 

Agilent Technologies Inc. requests that their press release NewsItemId: 20250324197742 issued March 24, 2025 “Agilent xCELLigence RTCA Instrumentation Applied in Recent FDA Approval” be removed.

Contacts

Recent Quotes

View More
Symbol Price Change (%)
AMZN  224.62
+3.93 (1.78%)
AAPL  275.05
+3.56 (1.31%)
AMD  214.47
+10.69 (5.24%)
BAC  51.81
+0.25 (0.48%)
GOOG  314.41
+14.76 (4.93%)
META  614.98
+20.73 (3.49%)
MSFT  475.34
+3.22 (0.68%)
NVDA  182.31
+3.43 (1.92%)
ORCL  199.44
+0.69 (0.34%)
TSLA  418.42
+27.33 (6.99%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.